Overall rank by patents
#4,212
Across all tracked assignees
USPTO PatentsView assignee record - 85 granted patents across 38 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
O&m holds 85 US patents across 38 technology areas, rank #4,212 of 50,000 tracked assignees.
O&M Halyard, Inc. has been granted 85 US utility patents between 2018 and 2025, placing O&M Halyard, Inc. at rank #4,212 across all assignees tracked by PlainPatent. This portfolio spans 38 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, O&M Halyard, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, O&m sits between Macrogenics, Inc. (85 patents, rank #4,208) and Pindrop Security, Inc. (85 patents, rank #4,216) - the closest US assignees by grant volume. The composite Innovation Score of 50.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 70 grants, compared with 15 in the 2015–2019 window, a +367% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. O&M Halyard, Inc.'s 16.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 38 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark O&M Halyard, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Macrogenics, Inc.
85 patents
NIFCO KOREA INC.
85 patents
NV BEKAERT SA
85 patents
Nobel Biocare Services AG
85 patents
Océ Holding B.V.
85 patents
Omrix Biopharmaceuticals Ltd.
85 patents
Otto Bock Healthcare LP
85 patents
Pindrop Security, Inc.
85 patents
O&M Halyard, Inc.
85 patents
What this shows O&M holds 85 patents at rank #4,212, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,212 in granted patent volume.
Other assignees with the most granted patents in O&M's primary technology class.
O&m's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 5 | 5.9% |
| 2019 | 10 | 11.8% |
| 2020 | 22 | 25.9% |
| 2021 | 15 | 17.6% |
| 2022 | 12 | 14.1% |
| 2023 | 11 | 12.9% |
| 2024 | 5 | 5.9% |
| 2025 | 5 | 5.9% |
Top 15 of 38 technology areas
Overall rank by patents
#4,212
Across all tracked assignees
50.8 out of 100
How to use this portfolio
O&m's 85 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.